Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A leukemic plasmacytoid dendritic cell line, PMDC05, with the ability to secrete IFN-α by stimulation via Toll-like receptors and present antigens to naïve T cells
Miwako Narita, Norihiro Watanabe, Akie Yamahira, et al.
Leukemia Research (2009) Vol. 33, Iss. 9, pp. 1224-1232
Closed Access | Times Cited: 43

Showing 1-25 of 43 citing articles:

Nrf2 negatively regulates STING indicating a link between antiviral sensing and metabolic reprogramming
David Olagnier, Aske M. Brandtoft, Camilla Gunderstofte, et al.
Nature Communications (2018) Vol. 9, Iss. 1
Open Access | Times Cited: 236
Neoplasms derived from plasmacytoid dendritic cells
Fabio Facchetti, Marta Cigognetti, Simona Fisogni, et al.
Modern Pathology (2016) Vol. 29, Iss. 2, pp. 98-111
Open Access | Times Cited: 121
Association of polymorphisms in TLR genes and in genes of the Toll-like receptor signaling pathway with cancer risk
Anton G. Kutikhin
Human Immunology (2011) Vol. 72, Iss. 11, pp. 1095-1116
Closed Access | Times Cited: 114
DC-Based Vaccines for Cancer Immunotherapy
Chunmei Fu, Li Zhou, Qing‐Sheng Mi, et al.
Vaccines (2020) Vol. 8, Iss. 4, pp. 706-706
Open Access | Times Cited: 111
DC-Derived Exosomes for Cancer Immunotherapy
Yi Yao, Chunmei Fu, Li Zhou, et al.
Cancers (2021) Vol. 13, Iss. 15, pp. 3667-3667
Open Access | Times Cited: 76
Plasmacytoid Dendritic Cells and Cancer Immunotherapy
Chunmei Fu, Li Zhou, Qing‐Sheng Mi, et al.
Cells (2022) Vol. 11, Iss. 2, pp. 222-222
Open Access | Times Cited: 44
Recurrent 8q24 rearrangement in blastic plasmacytoid dendritic cell neoplasm: association with immunoblastoid cytomorphology, MYC expression, and drug response
Kana Sakamoto, Ryohei Katayama, Reimi Asaka, et al.
Leukemia (2018) Vol. 32, Iss. 12, pp. 2590-2603
Closed Access | Times Cited: 72
Superior migration ability of umbilical cord-derived mesenchymal stromal cells (MSCs) toward activated lymphocytes in comparison with those of bone marrow and adipose-derived MSCs
Akiko Hori, Atsuko Takahashi, Yuta Miharu, et al.
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 5
Dendritic cell vaccination in acute myeloid leukemia
Sébastien Anguille, Yannick Willemen, Eva Lion, et al.
Cytotherapy (2012) Vol. 14, Iss. 6, pp. 647-656
Closed Access | Times Cited: 53
Tickling the TLR7 to cure viral hepatitis
Emily K. Funk, Shyam Kottilil, Bruce L. Gilliam, et al.
Journal of Translational Medicine (2014) Vol. 12, Iss. 1
Open Access | Times Cited: 35
Azithromycin impairs TLR7 signaling in dendritic cells and improves the severity of imiquimod-induced psoriasis-like skin inflammation in mice
Shi‐Wei Huang, Yi‐Ju Chen, Sin-Ting Wang, et al.
Journal of Dermatological Science (2016) Vol. 84, Iss. 1, pp. 59-70
Closed Access | Times Cited: 34
The Immunomodulatory Effect of Triptolide on Mesenchymal Stromal Cells
Haiping He, Atsuko Takahashi, Takeo Mukai, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 19
Modulation of the Immune System in Chronic Hepatitis C and During Antiviral Interferon-Free Therapy
A. Urbanowicz, Radosław Zagożdżon, Michał Ciszek
Archivum Immunologiae et Therapiae Experimentalis (2018) Vol. 67, Iss. 2, pp. 79-88
Open Access | Times Cited: 22
Differential and Overlapping Immune Programs Regulated by IRF3 and IRF5 in Plasmacytoid Dendritic Cells
Kwan T. Chow, Courtney Wilkins, Miwako Narita, et al.
The Journal of Immunology (2018) Vol. 201, Iss. 10, pp. 3036-3050
Open Access | Times Cited: 19
Harnessing dendritic cells for innovative therapeutic cancer vaccines
Joël Plumas
Current Opinion in Oncology (2021) Vol. 34, Iss. 2, pp. 161-168
Open Access | Times Cited: 13
CRISPR/Cas9 and AAV mediated insertion of β2 microglobulin-HLA-G fusion gene protects mesenchymal stromal cells from allogeneic rejection and potentiates the use for off-the-shelf cell therapy
Sohsuke Meshitsuka, Ryo Ninomiya, Tokiko Nagamura‐Inoue, et al.
Regenerative Therapy (2022) Vol. 21, pp. 442-452
Open Access | Times Cited: 9
Leveraging a powerful allogeneic dendritic cell line towards neoantigen-based cancer vaccines
Dalil Hannani, Estelle Leplus, Karine Laulagnier, et al.
Genes & Cancer (2023) Vol. 14, pp. 3-11
Open Access | Times Cited: 5
Progress of dendritic cell-based cancer vaccines for patients with hematological malignancies
Ming Ni, Jean‐Marc Hoffmann, Michael Schmitt, et al.
Expert Opinion on Biological Therapy (2016) Vol. 16, Iss. 9, pp. 1113-1123
Closed Access | Times Cited: 14
Maternal ω3 docosapentaenoic acid inhibits infant allergic dermatitis through TRAIL‐expressing plasmacytoid dendritic cells in mice
Soichiro Hirata, Takahiro Nagatake, Kento Sawane, et al.
Allergy (2020) Vol. 75, Iss. 8, pp. 1939-1955
Open Access | Times Cited: 13
Transformation of dendritic cells from plasmacytoid to myeloid in a leukemic plasmacytoid dendritic cell line (PMDC05)
Norihiro Watanabe, Miwako Narita, Akie Yamahira, et al.
Leukemia Research (2010) Vol. 34, Iss. 11, pp. 1517-1524
Closed Access | Times Cited: 16
Umbilical cord derived mesenchymal stromal cells in microcarrier based industrial scale culture sustain the immune regulatory functions
Hikari Kurogi, Atsuko Takahashi, Maya Isogai, et al.
Biotechnology Journal (2021) Vol. 16, Iss. 6
Closed Access | Times Cited: 11
TLR4 sensitizes plasmacytoid dendritic cells for antiviral response against SARS-CoV-2 coronavirus
King Hoo Lim, Lishi Wang, Eunice Dotse, et al.
Journal of Leukocyte Biology (2023) Vol. 115, Iss. 1, pp. 190-200
Open Access | Times Cited: 4
Induction of the ISR by AB5 subtilase cytotoxin drives IFN-I expression in pDCs via STING activation
Daniela Barros, Beatriz H. Ferreira, Paulina A García-González, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Generation of antigen-specific cytotoxic T lymphocytes using a leukemic plasmacytoid dendritic cell line as antigen presenting cells
Akie Yamahira, Miwako Narita, Tetsu Nakamura, et al.
Leukemia Research (2011) Vol. 35, Iss. 6, pp. 793-799
Closed Access | Times Cited: 11
Immunological influence of serum-free manufactured umbilical cord-derived mesenchymal stromal cells for steroid-resistant acute graft-versus-host disease
Tokiko Nagamura‐Inoue, Seiko Kato, Yuho Najima, et al.
International Journal of Hematology (2022) Vol. 116, Iss. 5, pp. 754-769
Closed Access | Times Cited: 6
Page 1 - Next Page

Scroll to top